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Abstract
Background: Tuberculosis (TB) remains one of the world’s deadliest communicable diseases. In Ethiopia,
tuberculosis patients have different pattern of health care seeking behavior. They usually adopt other approaches
like traditional healers and spiritual holy water sites before consulting public health facilities. This study was aimed
to assess the prevalence of smear positive pulmonary tuberculosis and associated risk factors among tuberculosis
suspects attending spiritual holy water sites.
Methods: A cross-sectional study was conducted from February 01, 2015 to March 30, 2015 in seven selected holy
water sites in Northwest Ethiopia. During the study period, a total of 1384 adult holy water users were screened for
PTB symptoms. A total of 382 pulmonary tuberculosis suspects participated in the study. Socio-demographic data
were collected using a semi-structured questionnaire. Spot-morning-spot sputum specimens were collected and
examined for acid fast bacilli using Auramine O fluorescence staining technique. Smear positive sputum samples
were tested by GeneXpert MTB/RIF assay for rifampicin resistance. Descriptive statistics, binary and multivariate
logistic regression analysis were employed using SPSS-16 software.
Results: The prevalence of smear positive pulmonary tuberculosis was 2.9% with point prevalence of 795/100, 000
holy water users. History of contact with tuberculosis patient (AOR = 9.174, 95% C.I = 2.195–38.34) and the number
of family members > 5 per household (AOR = 9.258, 95% C.I = 1.14–74.97) were significantly associated with smear
positive pulmonary tuberculosis. Rifampicin resistance was not detected from all smear positives by GeneXpert
MTB/RIF assay.
Conclusions: The prevalence of smear positive pulmonary tuberculosis in spiritual holy water sites was 7.4 fold
higher than the general population. History of contact with active tuberculosis patients and increased family size
were significantly associated with smear positive pulmonary TB. The national tuberculosis program should consider
spiritual holy water sites as potential foci for TB transmission and plan regular survey and health education in holy
water sites for effective TB prevention and control in the country.
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Background
Tuberculosis (TB) remains one of the world’s deadliest
communicable diseases [1]. Globally, the burden of TB
is increasing at alarming rate and continues to be a
major public health problem throughout the world with
increasing incidences in developing countries. Tubercu-
losis is ranked as the second leading cause of death from
an infectious disease worldwide, after human immuno-
deficiency virus (HIV) [2]. According to World Health
Organization (WHO) global 2014 TB report, an estimated
9.0 million people develop TB and 1.5 million died from
the disease in 2013 worldwide. Out of this more than half
(56%) were in South East Asia and western pacific regions.
African region accounts one quarter which had the highest
rates of cases and deaths relative to the population [1, 3].
Despite the availability of efficacious anti-TB treatments
for decades, TB remains a major global health problem [3].
The emergence of multidrug resistance tuberculosis (MDR-
TB) and the pandemic of human immunodeficiency virus/
acquired immunodeficiency syndrome (HIV/AIDS) worsen
the burden of TB in Africa including Ethiopia [4, 5]. In
Ethiopia, TB is a major cause of morbidity and mortality
[6]. Ethiopia ranked 7th among the 22 high burden coun-
tries where 80% of total TB cases reported [7]. According
to WHO 2014 report, the burden of TB in Ethiopia was
224, 211 and 32 per 100 000 population for new smear
positive cases, prevalence and mortality, respectively [1]. In
developing countries, the burden of TB is exacerbated by
different conditions such as malnutrition, HIV/AIDS and
also dependence on traditional healers which results in
treatment delays [6, 8, 9].
In Ethiopia, many TB cases in the community are un-
diagnosed [10, 11]. The case detection rate of smear
positive pulmonary TB is low compared with the 70%
target by WHO [6]. It is indicated that, one of the
underlying reason is that the high incidence countries
like Ethiopia rely on the passive case finding strategy,
which presupposes self presentation and willingness of
TB suspects to the public health care facilities [12, 13].
But, studies showed that in Africa including Ethiopia,
people with TB symptoms (TB suspects) first adopt other
approaches before consulting public health facilities. Pa-
tients with the symptom of TB have different patterns of
health seeking behavior and the period when to seek
health is related with delay in diagnosis and treatment of
tuberculosis [8, 14–17].
Tuberculosis patients initially visit informal health care
providers prior to their first consultation to the public
health facility. They prefer to seek treatment from a var-
iety of sites which includes spiritual holy water sites
(24%), private practitioners (13%), rural drug vendors (7%)
and traditional healers (3%). Dependence on informal
health care providers results delay in diagnosis and initi-
ation of anti-TB treatment at public health care institutions.
Pulmonary tuberculosis (PTB) patients delay seeking care
at public health facilities while getting treatment from infor-
mal sources [8]. This increases the likelihood of developing
MDR-TB and progression of disease which results in-
creased mortality and enhanced TB transmission in the
community [18].
In Ethiopia, holy water is used as an alternative treat-
ment. Even though there are no available documented
data to show the proportion of people that use holy
water as their treatment option, it is a public knowledge
that many Ethiopians use it as an alternative treatment for
various diseases. Specifically, people with cough symptoms
or other pulmonary TB suspects visit traditional healers
and holy water sites as a source of care for their illness
[8, 14]. Mostly, patients stay close to holy water sites for
an extended duration of time until they are perceived to
be cured.
Holy water sites are found at designated places with
springs that are believed to have a power to cure individ-
uals from various diseases. In this setting, a number of
people who seek holy water treatment for their illness
come together from various localities, leaving their homes
and stay close together for certain period of time in houses
built around holy water sites. These houses are small,
crowded and poorly ventilated which increase the risk of
TB transmission.
Most reports of TB were from public health care insti-
tutions but a high prevalence of TB was found by few
community surveys. A number of TB patents (TB sus-
pects) first visit informal health care providers rather
than reporting to public health facilities. This threatens
transmission of TB in the community and makes the
passive case detection rate low. In Northwest Ethiopia,
two-thirds of pulmonary TB in the community were un-
diagnosed and the prevalence of new sputum smear
positive TB in the community was 174 per 100, 000 pop-
ulations [10].
Even though studies indicate that pulmonary TB
suspects and TB patients visit traditional healers and
spiritual holy water sites as their treatment option, the
prevalence of TB in spiritual holy water sites in Northwest
Ethiopia has not been reported to date. Therefore, this
study was conducted to estimate the prevalence and asso-
ciated risk factors of smear positive pulmonary tubercu-
losis among those people who use spiritual holy water
sites from February 01, 2015 to March 30, 2015.
Methods
Study area, study design and participants
A cross-sectional study was conducted in 7 selected holy
water sites found in North Gondar zone: two holy water
sites in Gondar town, two in Chilga district, two in
Dembia woreda and one in Tikele Dingay. North Gondar
zone is located 739 km away from the capital city, Addis
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Ababa towards the Northwest part of Ethiopia. Selected
holy water sites are among popularly believed sites for
holy water treatment which can accommodate large num-
bers of people and the high number of holy water users
that travel to these sites every year. Northwest part of the
country contains many holy water sites and high propor-
tion of holy water users. In North Gondar zone, northwest
part of Ethiopia, 95% of the population practice Ethiopian
Orthodox Christianity which widely practice a faith based
therapy with holy water [19].
The study was conducted from February 01, 2015 to
March 30, 2015. The minimum sample size (n) was de-
termined by using single population proportion formula
[n = (Z α/2) 2 P (1-P) /d2], where Zα/2 = the value under
standard normal table at 95% level of confidence which
is 1.96, expected prevalence P, set at 50% to yield maximum
sample size, d = precision which was set at 5%. Including
10% non response rate, the final sample size was 422 PTB
suspects. However, a total of 382 PTB suspects participated
in the study.
Data collection and laboratory methods
Holy water users ≥ 15 years of age were interviewed
using a questionnaire to identify pulmonary TB suspects.
According to the national TB manual, individuals with
persistent cough for two weeks or more and presence of
other symptoms i.e. expectoration, blood contained spu-
tum, fever, chest pain, shortness of breath, fatigue, night
sweats, loss of appetite, loss of body weight and contact
history with active TB patients were considered as sus-
pects for PTB [6]. Socio-demographic characteristics in-
cluded age, gender, occupation, residence, marital status,
monthly income, family size and educational status.
Other potential risk factors for TB included previous
history of TB, history of contact with patients with active
TB or chronic cough; history of previous stay at holy
water sites; duration of stay at holy water sites; and shar-
ing a room at these sites. Completeness of questionnaire
was checked and three consecutive sputum samples
(spot-morning-spot) were collected from each PTB sus-
pects using clean, dry and leak-proof sputum cups. Spu-
tum samples were immediately placed in a cold box and
transported to Gondar University Hospital for laboratory
processing. The samples were processed by Auramine O
staining, fluorescent microscopy for acid fast bacilli (AFB)
examination [20]. Smear positive samples were stored at
-20°C until used and processed by GeneXpert MTB/RIF
assay for Rifampicin (RIF) resistance testing [21–23].
Data analysis and interpretation
Data were entered by using Epi info version 7.0 and trans-
ferred in to SPSS version 16 for cleaning, categorization
and analysis. The results were summarized using de-
scriptive statistics including frequencies and proportions.
Bivariate analysis was conducted to identify the association
between each independent variable with the outcome vari-
ables. Multivariate analysis was employed to identify inde-
pendent predictors associated with the outcome variables.
In the Multivariate analysis, adjusted odds ratio (AOR)
and corresponding 95% confidence intervals were re-
trieved. Those variables with P value of less than 0.05 were
considered as statistically significant.
Results
Socio demographic characteristics of respondents
Of the total 1384 holy water users, 382 (27.6%) individ-
uals were identified as TB suspects. Among the pulmon-
ary tuberculosis suspects, 253 (66.2%) were male while
129 (33.8%) were female. The mean (SD) age of study
participants was 39 (17.2) years. More than half, 235
(61.5%) of respondents were married. Two hundred
eighty (73.3%) participants were rural residents while
51.3% were farmers. Two hundred (52.4%) study partici-
pants had greater than 5 family members per household
[Table 1].
Prevalence of smear positive pulmonary tuberculosis
Among 382 study subjects, 11 (2.9%) were smear positive
for acid fast bacilli by Auramine O fluorescence staining
technique. The point prevalence of smear positive PTB
was 795/100,000 holy water users. Of total positives, 9/11
(81.8%) and 2/11 (18.2%) were males and females, respect-
ively. The majority of smear positives, 8/11 (72.7%) were
rural dwellers. Seven smear positives (63.6%) were mar-
ried. A high proportion of smear positive pulmonary tu-
berculosis cases were reported among those > = 46 years
old, 7/11 (63.6%) and among those respondents who had
greater than 5 family members per household, 10/11
(90.9%). In addition, 7/11 (63.6%) of smear positives were
farmers. However, none of smear positive cases were re-
sistant for rifampicin [Table 2].
Risk factors for smear positive pulmonary tuberculosis
Based on bivariate logistic regression, family size was
significantly associated with smear positive pulmonary
tuberculosis (COR= 9.526, 95% C.I = 1.207-75.169) [Table 3].
Similarly, history of contact with active TB patient was
significantly associated with smear positive pulmonary
tuberculosis (COR = 5.649, 95% C.I = 1.673 - 19.071).
However, other factors such as history of previous TB,
knowledge about TB, history of previous stay at holy
water sites and duration of days spent at holy water sites
were not significantly associated with smear positive pul-
monary tuberculosis [Table 4].
After multivariate logistic regression analysis, family
size (p = 0.037) and history of contact with tuberculosis
patient (p = 0.002) were significantly associated with smear
positive pulmonary tuberculosis. Respondents who have
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greater than five family members per household were
about nine times (AOR = 9.258, 95% C.I = 1.14–74.97)
more likely to develop smear positive pulmonary tuber-
culosis compared to those with < 5 family members per
household. With respect to contact history, those re-
spondents who had previous history of contact with tu-
berculosis patient were about nine times (AOR = 9.174,
95% C.I = 2.195–38.34) more likely to develop smear
positive pulmonary tuberculosis than those who had no
history of contact [Table 5].
Discussion
This study provide insights on the prevalence of smear
positive pulmonary tuberculosis and point out possible
risk factors associated with smear positive PTB among
holy water users. The point prevalence of 795/100, 000
holy water users observed in this study was 7.4 times
higher than the results of Ethiopian national population
based TB prevalence survey [24]. This difference might
be due to the difference in the study population in which
the national TB survey was conducted which excluded
congregate settings and high risky areas like monasteries
and holy water sites. The higher rate of smear positive
cases at holy water sites could be due to overcrowding,
close contact and poorly ventilated conditions which
favor the high rate of bacilli transmission since a number
of holy water users stayed together for an extended dur-
ation. In addition, it previously was noted that TB sus-
pects and TB patients visit traditional healer sites like
holy water sites as their treatment option before reach-
ing to the public health facilities [8, 14]. Therefore, the
high rate of smear positive cases detected at holy water
sites could be due to the high number of TB suspects
visiting holy water sites as their treatment option. Most
people who attend holy water sites prefer to manage
various diseases, including TB spiritually and consider
spiritual holy water sites as their preferred treatment
Table 1 Socio-demographic characteristics of pulmonary
tuberculosis suspects (N = 382)
Characteristics Frequency (%)
Gender Male 253 (66.2)
Female 129 (33.8)
Age 15-30 126 (33.0)
31-45 136 (35.6)
≥46 120 (31.4)
Residence Rural 280 (73.3)
Urban 102 (26.7)




Education status Can’t read and write 177 (46.3)
Primary school 150 (39.3)
High school (9-12) 47 (12.3)
>12 grade 8 (2.1)
Total family size 1- 5 182 (47.6)
>5 200 (52.4)
Occupation Farmer 196 (51.3)




Total monthly income <500 ETB 246 (64.4)
500-1000 ETB 79 (20.7)
>1000 ETB 57 (14.9)
aReligious leaders, daily laborers, merchant, non-employed ETB = Ethiopian Birr
Table 2 Proportion of smear positive pulmonary tuberculosis
with socio-demographic characteristics of study subjects
Variables Prevalence of smear positive PTB
Positive No (%) Negative No (%)
Gender Male 9 (81.8) 244 (65.8)
Female 2 (18.2) 127 (34.2)
Age groups 15-30 1 (9.1) 125 (33.7)
31 -45 3 (27.3) 133 (35.8)
≥46 7 (63.6) 113 (30.5)
Residence Rural 8 (72.7) 272 (73.7)
Urban 3 (27.3) 99 (26.3)
Marital status Single 2 (18.2) 98 (26.4)
Married 7 (63.6) 228 (61.5)
Divorced 1 (9.1) 12 (3.2)
Widowed 1 (9.1) 33 (8.9)
Education status Can’t read and write 6 (54.5) 171 (46.1)
Primary school 3 (27.3) 147 (39.6)
High school (9-12) 1 (9.1) 46 (12.4)
>12 grade 1 (9.1) 7 (87.5)
Total family size 1 -5 1 (9.1) 181 (48.8)
>5 10 (90.9) 190 (51.2)
Occupation Farmer 7 (63.6) 189 (50.9)
House wife 1 (9.1) 56 (15.1)
Employed 1 (9.1) 43 (11.6)
Student 1 (9.1) 43 (11.6)
Othersa 1 (9.1) 40 (10.8)
Total monthly
income
<500 ETB 9 (81.8) 237 (63.1)
500 -1000 ETB 1 (9.1) 78 (21.0)
>1000 ETB 1 (9.1) 56 (15.1)
Total 11 (2.9) 371 (97.1)
aReligious leaders, daily laborers, merchant, non-employed, ETB = Ethiopian birr
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option [25]. In Ethiopia, traditional medicines including
holy water sites are used by 80% of the population [26].
Most people from rural residences and older age groups
prefer to consult spiritual sites like holy water for their
illness rather than public health care institutions due to
different reasons such as lack of awareness, long distance of
public health care facilities and socio-economic factors [8].
The result of this study is similar to the result of a
study conducted in rural district of southern Ethiopia
which reported 3% smear positive PTB among PTB sus-
pects [27]. However, the prevalence of smear positive
TB in this study was lower than the prevalence in the
previous reports in Pakistan, 28.3% [28], Rwanda, 17.3%
[29], Zambia, 28% [30] and in Ethiopia: Nekemit refer-
ral hospital 9.41% [31], Bale Goba and Robe hospitals
9.2% [32] and Agaro teaching health center, 10.9% [33].
This difference might be due to differences in the study
populations as the previous studies were conducted
among clinically TB suspected patients at public health
care institutions. Patients usually visit the public health
care facilities after they tried other treatment options.
In this study, the total family size per household was
found to be statistically significant with smear positive
pulmonary tuberculosis. This finding was consistent with
cross sectional institution based studies in Bale Goba
and Robe hospitals [32], and the Methara sugar factory
hospital [34]. This might be due to the fact that poverty,
malnutrition and over-crowded living conditions in-
crease the risk of TB transmission [6, 35]. Since the
transmission of tuberculosis is mainly indoor, living in
large family size per household creates overcrowding
conditions and increases the risk of acquiring tubercu-
losis. The other possible reason might be due to the fact
that people with high number of family members tend
to be of lower socioeconomic status.
In this study the prevalence of smear positive PTB was
significantly associated with history of contact with active
TB patents. Similar findings were reported from studies
conducted in different part of Ethiopia [32, 36, 37]. Trans-
mission of tuberculosis is mainly through aerosolized
droplets and close contact with patients with active PTB
facilitate acquisition of TB. If the person with tuberculosis
Table 3 Bivariate analysis of socio-demographic variables of study subjects associated with smear positive pulmonary tuberculosis
Variables Prevalence of smear positive PTB p-value
Positive No Negative No COR (95% C.I)
Gender Male 9 244 2.432 (0.499-11.003) 0.281
Female 2 127 1
Age groups 15-30 1 125 1 0.372
31 -45 3 133 2.280 (0.289-27.464)
≥46 7 113 7.743 (0.938 -63.912) 0.057
Residence Rural 8 272 0.971 (0.252-3.732) 0.965
Urban 3 99 1
Marital status Single 2 98 1 0.444
Divorced/Widowed 2 45 2.178 (0.297-15.955)
Married 7 228 1.504 (0.307-7.371) 0. 614
Education status Can’t read and write 6 171 0.246 (0.026-2.325) 0.221
Primary school 3 147 0.143 (0.013-1.554) 0.110
High school (9-12) 1 46 0.152 (0.009-2.721) 0.201
>12 grade 1 7 1
Family size 1 -5 1 181 1 0.032
>5 10 190 9.526 (1.207-75.169)
Occupation Farmer 7 189 1.481 (0.177-12.378) 0.717
House wife 1 56 0.714 (0.043-11.762) 0.814
Employed 1 43 0.930 (0.056-15.375) 0.960
Student 1 43 0.930 (0.056-15.375) 0.960
Othersa 1 40 1
Total monthly income <500 ETB 9 237 2.127 (0.264-17.132) 0.478
500 -1000 ETB 1 78 0.718 (0.044-11.724) 0.816
>1000 ETB 1 56 1
aReligious leaders, daily laborers, merchant, non-employed, ETB = Ethiopian birr, No = number
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is remaining active and untreated, it can have the possibil-
ity to infect 10 up to 15 people per year [38]. Mycobacter-
ium tuberculosis is carried in airborne particles called
droplet nuclei which are 1μm up to 5μm in diameter.
Infectious droplet nuclei are generated from active tuber-
culosis patients during coughing, sneezing, speaking or
singing. These small droplet nuclei can remain suspended
in the air for several hours and transmitted to other
nearby person through inhalation.
All smear positive PTB cases tested by GeneXpert
MTB/RIF assay did not show resistance for RIF. Globally
about 3.6% of new TB cases and 20.2% of previously
treated cases had MDR-TB [3]. A study in Nigeria showed
that previous history of anti-TB treatment was a significant
Table 4 Bivariate analysis of risk factors for smear positive pulmonary tuberculosis among study subjects
Variables Positive N Negative N COR (95% CI) p- value
History of contact with chronic coughers 0.181
Yes 6 128 2.278 (0.682-7.609)
No 5 243 1a
History of contact with TB patients 0.005
Yes 6 65 5.649 (1.673-19.071)
No 5 306 1a
Heard about PTB disease 0.121
Yes 9 349 1a
No 2 22 3.525 (0.718-17.315)
Know PTB is transmittable disease 0.835
Yes 8 280 1a
No 3 91 1.154 (0.300-4.441)
Had PTB disease before 0. 351
Yes 1 13 2.754 (0.328-23.146)
No 10 358 1a
History of previous stay at holy water sites 0.212
Yes 7 164 2.209 (0.636-7.675)
No 4 207 1a
No of days spent at HWS 0.987
1-17 days 8 269 1.011 (0.263-3.886)
> 17 days 3 102 1a
Sharing containers for drinking at HWS 0.093
Yes 9 202 3.765 (0.802-17.663)
No 2 169 1a
Share room at HWS
Yes 10 252 4.722 (0.598-37.316) 0.141
No 1 119 1a
aReference category, COR = crude odds ratio, 95% CI = 95% confidence interval, HWS = Holy water site
Table 5 Multivariate analysis of risk factors for smear positive pulmonary tuberculosis among study subjects
Variables Positive No Negative No COR (95% CI) P- value AOR (95% CI) P- value
Familysize
1-5 1 181 1a 1a 0.037
> 5 10 190 9.52 (1.207-75.169) 0.032 9.258 (1.14-74.97)
History of contact with TB patients
Yes 6 65 5.64 (1.673-19.071) 0.005 9.174 (2.195- 38.34) 0.002
No 5 306 1a 1a
AOR = adjusted odds ratio, 95% CI = 95% confidence interval, aReference category
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factor for the development of drug resistance and MDR-TB
[39]. In the present study 14 (3.7%) of the respondents were
presented with history of previous anti-TB treatment. In
addition to this, one of the smear positive cases was previ-
ously treated for PTB. In Amhara region, the prevalence of
MDR-TB among new and retreated patients was 1.8% and
18.5%, respectively. Previous drug exposure was signifi-
cantly associated with the development of drug resistance
[40]. The reason for absence of RIF resistant cases in this
study might be due to small number of smear positive PTB
cases tested for rifampicin resistance. The presence of indi-
viduals with previous history of TB and history of anti-TB
treatment in these study sites which is a major risk factor
for the development of drug resistance could indicate the
potential risk for transmission of MDR-TB among holy
water users.
The limitation of this study was the use of direct
smear microscopy alone for the diagnosis of TB. It may
underestimate the prevalence of PTB in this study popu-
lation. The use of advanced laboratory techniques like
culture and molecular assays could give the best preva-
lence estimate of PTB among the study subjects.
Conclusions
The prevalence of smear positive pulmonary tuberculosis
in holy water sites was found to be 7.4 fold higher than
the prevalence in the general population in Ethiopia.
Previous history of contact with active tuberculosis pa-
tients and increased number of family members were
identified as significant risk factors for smear positive
pulmonary tuberculosis. Therefore, community health
programs should consider holy water sites for health
education, regular assessment of PTB suspects and refer
to public health care institutions for early diagnosis and
initiation of anti-TB treatment. Furthermore, large scale
studies should be conducted using advanced laboratory
techniques in holy water sites to better understand its
impact for the transmission of TB, including MDR-TB,
in the community.
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